Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Flux Power Holdings Inc (FLUX) vs Eli Lilly And Co (LLY) Price & Performance

Flux Power Holdings IncTrade
Eli Lilly And CoTrade

Price performance (Past 24H)

Key statistics

Flux Power Holdings Inc vs Eli Lilly And Co — how do they compare? Flux Power Holdings Inc trades at $0.63 (market cap $11.23M), while Eli Lilly And Co trades at $1,215.48 (market cap $1.08T). The key difference: Eli Lilly And Co is far larger — about 96171× Flux Power Holdings Inc's market cap, and Eli Lilly And Co pays a 0.57% dividend while Flux Power Holdings Inc pays none. Which is the better fit depends on your goals.

FLUXLLY
Market Cap
$11.23M$1.08T
Sector
UtilitiesHealth
52-Week High
$6.66$1.24K
52-Week Low
$0.51$639.43
Enterprise Value
$17.39M$1.13T
Dividend Yield
0.57%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Flux Power Holdings Inc

FLUX trades at $0.5408, up 3.21% today, but technical indicators signal a bearish trend with selling pressure across moving averages. The company reported revenue of $66.43M in 2025 but a net loss of $6.67M, with profitability metrics like ROE at -52.27% reflecting operational challenges. Recent news highlights product launches like SkyEMS 3.0 and an upcoming earnings call on August 20, 2026.

Despite unanimous analyst buy ratings, FLUX faces significant risks from persistent losses and negative cash flow projections. Investment appeal hinges on execution of growth initiatives in lithium-ion storage, but high volatility and competitive pressures warrant caution for equity investors.

Eli Lilly And Co

Eli Lilly (LLY) trades at $1,221.21, down 0.84% today, but maintains strong bullish momentum with consistent earnings beats and robust revenue growth. The stock shows technical strength with bullish moving averages and support at $1,207, while fundamentals reveal exceptional profitability with 33.53% net margins and 48% revenue growth in Q2 2026. Recent news highlights the company's aggressive protection of its obesity drug pipeline against black market sales.

LLY presents a compelling growth story with dominant market positioning in weight-loss drugs and strong analyst support (73% buy ratings). Key risks include regulatory scrutiny and competitive pressures, but the company's raised guidance and pipeline advancements support continued upside toward the $1,380 consensus target.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Flux Power Holdings Inc

Flux Power designs and manufactures lithium-ion battery packs for industrial vehicles. Its sustainable energy solutions power material handling equipment like forklifts and airport ground support vehicles.

Read more on FLUX

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Read more on LLY